Low-density lipoprotein particle profiles compared with standard lipids measurements in the association with asymptomatic intracranial artery stenosis.

Low-density lipoprotein particle profiles compared with standard lipids measurements in the association with asymptomatic intracranial artery stenosis.

Fuente:Scientific Reports

Extracto: These findings suggest that evaluating LDL-p levels alongside LDL-c may aid in identifying adults at a higher risk for ICAS.

Claves:Intracranial artery stenosis (ICAS), Low-density lipoprotein cholesterol (LDL-c), Low-density lipoprotein particle (LDL-p)

Cita:Sci Rep 2024 May 10; 14 (1) : 10765.

Autor/es:Vu, Thien (a)
Yano, Yuichiro (b)

institución:(a) NCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan.
(b) Department of Cardiac Surgery, Cardiovascular Center, Cho Ray Hospital, Ho Chi Minh City, Vietnam.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41598-024-59523-4

New evidence calls into question NICE's endocarditis prevention guidance.

New evidence calls into question NICE's endocarditis prevention guidance.

Fuente:British Dental Journal

Extracto: Given the new evidence, a NICE guideline review would seem appropriate so that UK high-risk patients can receive the same protection afforded high-risk patients in the rest of the world.

Cita:Br Dent J 2024 May; 236 (9) : 702-708.

Autor/es:Thornhill, Martin (a)
Prendergast, Bernard (b)

institución:(a) Professor of Translational Research in Dentistry, Unit of Oral and Maxillofacial Medicine, Surgery and Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield, UK. m.thornhill@sheffield.ac.uk.
(b) Professor of Cardiology, Guy´s and St Thomas´ Hospital, London and Chair of Cardiology, Cleveland Clinic, London, UK.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41415-024-7344-5

Prevention of infective endocarditis in at-risk patients: how should dentists proceed in 2024?

Fuente:British Dental Journal

Extracto: The article also provides practical information and advice for dentists on how to manage patients at increased IE risk who present for dental treatment.

Cita:Br Dent J 2024 May; 236 (9) : 709-716.

Autor/es:Thornhill, Martin (a)
Prendergast, Bernard (b)

institución:(a) Professor of Translational Research in Dentistry, Unit of Oral and Maxillofacial Medicine, Surgery and Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield, UK. M.Thornhill@Sheffield.ac.uk.
(b) Professor of Cardiology, Guy´s and St Thomas´ Hospital, London and Chair of Cardiology, Cleveland Clinic, London, UK.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41415-024-7355-2

The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.

The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.

Fuente:Nature Communications

Extracto: Here, we show that effects of lanifibranor on liver histology in MASH are accompanied with CMH improvement, indicative of potential cardiovascular clinical benefits.

Cita:Nat Commun 2024 May 10; 15 (1) : 3962.

Autor/es:Cooreman, Michael P (a)
Butler, Javed (b)

institución:(a) Research and Development, Inventiva, New York, NY, USA. Michael.Cooreman@inventivapharma.com.
(b) Research and Development, Inventiva, Daix, France. Michael.Cooreman@inventivapharma.com.

Conflicto:M.P.C., L.D., P.H.M., M.B. and P.B. are employees of Inventiva. J.L.J. is a consultant for Inventiva. D.R.B. has received honoraria from Inventiva via Translational Medicine Academy. J.B. has served as a consultant for Abbott, American Regent, Amgen, Applied Therapeutic, AskBio, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiac Dimension, Cardiocell, Cardior, Cardiorem, CSL Bearing, CVRx, Cytokinetics, Daxor,... Edwards, Element Science, Faraday, Foundry, G3P, Innolife, Impulse Dynamics, Imbria, Inventiva, Ionis, Lexicon, Lilly, LivaNova, Janssen, Medtronics, Merck, Occlutech, Owkin, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Regeneron, Renibus, Roche, Salamandra, Sanofi, SC Pharma, Secretome, Sequana, SQ Innovation, Tenex, Tricog, Ultromics, Vifor, and Zoll. RPG received research support or honoraria form Amgen, Anthos Therapeutics, Daiichi Sankyo, Ionis, Dr. Reddy’s Laboratories, Medical Education Resources, Menarini, SAJA Pharmaceuticals, Servier, SUMMEET, and consults for Artivion, Beckman Coulter, Daiichi Sankyo, Gilead, Inari, Inventiva, PhaseBio Pharmaceuticals, Samsung and Aventis. FZ reports personal fees from 89Bio, Abbott, Acceleron, Applied Therapeutics, Bayer, Betagenon, Boehringer, BMS, CVRx, Cambrian, Cardior, Cereno pharmaceutical, Cellprothera, CEVA, Inventiva, KBP, Merck, NovoNordisk, Owkin, Otsuka, Roche Diagnostics, Northsea, USa2, having stock options at G3Pharmaceutical and equities at Cereno, Cardiorenal, Eshmoun Clinical research and being the founder of Cardiovascular Clinical Trialists. MFA received grants from Boehringer-Ingelheim, Gilead, Hanmi, Inventiva, Madrigal, Novo Nordisk; honoraria from Clinical Care Options, Fishawack, Medscape, Terra Firma, CLDF; royalties from Up-to-Date; consults for 89Bio, BMS, Hanmi, Inventiva, Intercept, Madrigal, Merck, Novo Nordisk. SMF received grants from Astellas, Falk Pharma, Genfit, Gilead Sciences, GlympsBio, Janssens Pharmaceutica, Inventiva, Merck Sharp & Dome, Pfizer, Roche; honoraria from Abbvie, Allergan, Bayer, Eisai, Genfit, Gilead Sciences, Janssens Cilag, Intercept, Inventiva, Merck Sharp & Dome, Novo Nordisk, Promethera, Siemens; serves as consultant for Abbvie, Actelion, Aelin Therapeutics, AgomAb, Aligos Therapeutics, Allergan, Alnylam, Astellas, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristoll-Meyers Squibb, CSL Behring, Coherus, Echosens, Dr. Falk Pharma, Eisai, Enyo, Galapagos, Galmed, Genetech, Genfit, Genflow Biosciences, Gilead Sciences, Intercept, Inventiva, Janssens Pharmaceutica, PRO.MED.CS Praha, Julius Clinical, Madrigal, Medimmune, Merck Sharp & Dome, Mursla Bio, NGM Bio, Novartis, Novo Nordisk, Promethera, Roche, Siemens Healthineers.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41467-024-47919-9

A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients.

A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients.

Fuente:Bmc Infectious Diseases

Extracto: Therefore, every patient should be assessed for the risk of thromboembolic complications and provided with an appropriate thromboprophylaxis management plan tailored to their individual needs.

Claves:Arterial thromboembolism, Deep vein thrombosis, Mortality, Myocardial infarction, Pulmonary embolism, Stroke, Venous thromboembolism

Cita:BMC Infect Dis 2024 May 10; 24 (1) : 484.

Autor/es:Othman, Hanies Yuhana (a)
Zaki, Izzati Abdul Halim (b)

institución:(a) Department of Clinical Pharmacy, Fakulti Farmasi, Universiti Teknologi MARA Cawangan Selangor, Kampus Puncak Alam, Bandar Puncak Alam, Selangor, Malaysia.
(b) Department of Clinical Pharmacy, Fakulti Farmasi, Universiti Teknologi MARA Cawangan Selangor, Kampus Puncak Alam, Bandar Puncak Alam, Selangor, Malaysia.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12879-024-09374-1

Lipids as potential mediators linking body mass index to diabetes: evidence from a mediation analysis based on the NAGALA cohort.

Lipids as potential mediators linking body mass index to diabetes: evidence from a mediation analysis based on the NAGALA cohort.

Fuente:Bmc Endocrine Disorders

Extracto: Our fresh findings suggested that lipid parameters partially mediated the association of BMI with diabetes risk; this result indicated that in the context of diabetes risk screening and disease management, it is important to not only monitor BMI but also pay attention to lipid parameters, particularly HDL-C and HDL-C-related lipid ratio parameters.

Claves:Body mass index, Diabetes, Indirect effect, Lipid parameters, Mediation analyses

Cita:BMC Endocr Disord 2024 May 10; 24 (1) : 66.

Autor/es:Lu, Song (a)
Wang, Qun (b)

institución:(a) Department of Cardiology, The First Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
(b) Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12902-024-01594-5

Association between ideal cardiovascular health and abnormal glucose metabolism in the elderly: evidence based on real-world data.

Association between ideal cardiovascular health and abnormal glucose metabolism in the elderly: evidence based on real-world data.

Fuente:Bmc Geriatrics

Extracto: Each increase in an ideal CVH measure may effectively reduce the risk of abnormal glucose metabolism by more than 20%.

Claves:Abnormal glucose metabolism, Cardiovascular health, Elderly

Cita:BMC Geriatr 2024 May 10; 24 (1) : 414.

Autor/es:Ren, Yongcheng (a)
Wang, Wenwen (b)

institución:(a) Affiliated Hospital of Huanghuai University, Zhumadian Central Hospital, Zhumadian, 463000, He'nan, People's Republic of China. renyongcheng@huanghuai.edu.cn.
(b) Institute of Health Data Management, Huanghuai University, Zhumadian, 463000, He'nan, People's Republic of China. renyongcheng@huanghuai.edu.cn.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12877-023-04632-4

Anaesthesia management of a patient with Bethlem Myopathy for elective tonsillectomy

Anaesthesia management of a patient with Bethlem Myopathy for elective tonsillectomy

Fuente:Bmc Anesthesiology

Tipo de trabajo:Caso clínico

Extracto: Bethlem Myopathy, while often exhibiting a mild clinical course, can present anaesthetic challenges. Awareness of potential complications including a difficult airway, cardiovascular and respiratory implications as well as the need for specialised monitoring and positioning is crucial to ensure a safe peri-operative course.

Claves:Bethlem Myopathy, Collagen VI-related myopathy, Hereditary muscular disorder

Cita:BMC Anesthesiol 2024 May 10; 24 (1) : 173.

Autor/es:McGarrigle, Conor (a)
McGrath, Launcelot (b)

institución:(a) Our Lady of Lourdes Hospital, Drogheda, Ireland. mcgarric@tcd.ie.
(b) Our Lady of Lourdes Hospital, Drogheda, Ireland.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12871-024-02539-0

Association between life's essential 8 and frailty status among cancer survivors in the United States: a cross-sectional analysis.

Association between life's essential 8 and frailty status among cancer survivors in the United States: a cross-sectional analysis.

Fuente:Bmc Public Health

Extracto: Studies have found that the higher the LE8 score, the less likely a cancer patient is to develop debilitating symptoms.This indicates that the LE8 scores may provide an opportunity for interventions aimed at improving the prognosis of cancer patients.

Claves:Cancer survivors, Cross-sectional study, Frailty, Life’s essential 8, NHANES

Cita:BMC Public Health 2024 May 10; 24 (1) : 1287.

Autor/es:Qiu, Xiuxiu (a)
Wu, Qidong (b)

institución:(a) Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
(b) Department of Intensive Care Unit, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12889-024-18741-1

Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.

Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.

Fuente:Bmc Cardiovascular Disorders

Tipo de trabajo:Guía

Extracto: The 2013 ACA/AHA Guideline release is associated with trend improvements in the long-term MACE Survival for Diabetes group and optimal statin use for ASCVD group. These significant associations might indicate a potential positive long-term impact of the 2013 ACA/AHA Guideline on better health outcomes for primary prevention groups and an immediate potential impact on statin prescribing behaviors in higher-at-risk groups. However, further investigation is required to confirm the causal effect of the 2013 ACA/AHA Guideline.

Claves:Cardiovascular disease, Diabetes, Generic atorvastatin, Guideline implementation, Interrupted time series analysis, Long-term effect, MACE, Policy effect

Cita:BMC Cardiovasc Disord 2024 May 10; 24 (1) : 245.

Autor/es:Yew, Pui Ying (a)
Loth, Matt (b)

institución:(a) Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
(b) Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12872-024-03921-z

Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction.

Fuente:Bmc Cardiovascular Disorders

Tipo de trabajo:Guía

Extracto: Our results demonstrate cardiologists were more likely to adjust GDMT than general medicine physicians. Future focus on improving GDMT prescribing should target providers other than cardiologists to improve care in patients with HFrEF.

Claves:Evidence-based therapy, Guideline-directed medical therapy (GDMT), Heart failure with reduced ejection fraction (HFrEF), Medications

Cita:BMC Cardiovasc Disord 2024 May 11; 24 (1) : 247.

Autor/es:Cordwin, David J (a)
Guidi, Jessica (b)

institución:(a) College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
(b) Medical School, University of Michigan, Ann Arbor, MI, USA.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12872-024-03911-1

Analysis of onset-to-door time and its influencing factors in Chinese patients with acute ischemic stroke during the 2020 COVID-19 epidemic: a preliminary, prospective, multicenter study.

Analysis of onset-to-door time and its influencing factors in Chinese patients with acute ischemic stroke during the 2020 COVID-19 epidemic: a preliminary, prospective, multicenter study.

Fuente:Bmc Health Services Research

Extracto: Most patients with AIS fail to reach a hospital within the critical 3-h window. The following measures are recommended to reduce pre-hospital delays: reasonable distribution of hospitals accessible to nearby residents, minimizing interhospital transfer, paying attention to patients with mild stroke, and encouraging patients to use ambulance services. Pre-hospital delays for patients can be reduced by implementing these measures, ultimately improving the timeliness of treatment and enhancing patient prognosis. This study was carried out amid the COVID-19 pandemic, which presented challenges and constraints.

Claves:Acute ischemic stroke, China, Current situation, Onset-to-door time, Pre-hospital delay, Risk factors

Cita:BMC Health Serv Res 2024 May 10; 24 (1) : 615.

Autor/es:Liao, Yuqi (a)
Qi, Wenwei (b)

institución:(a) School of Medicine, Shenzhen University, Shenzhen, China.
(b) National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12913-024-11088-8

Laboratory-based surveillance of chronic kidney disease in people with private health coverage in Brazil.

Laboratory-based surveillance of chronic kidney disease in people with private health coverage in Brazil.

Fuente:Bmc Nephrology

Tipo de trabajo:Guía

Extracto: The estimated prevalence of CKD was 3.8%, and approximately 10% of the participants were in the categories of high or very high-risk of the disease. While almost 20% of beneficiaries with PHC had serum creatinine data, fewer than 1% underwent tests for proteinuria. This study was one of the largest ever conducted in Brazil and the first one to use the 2021 CKD-EPI equation to estimate the prevalence of CKD.

Claves:Chronic kidney disease, Epidemiology, Information systems in clinical laboratory, Prevalence, Supplementary health

Cita:BMC Nephrol 2024 May 10; 25 (1) : 162.

Autor/es:Samaan, Farid (a)
Silveira, Rubens Carvalho (b)

institución:(a) Department of High Complexity Patients, Hapvida NotreDame Intermédica, Rua Hipódromo, 987 - Mooca, São Paulo, SP, 03164-140, Brazil. farid_samaan@yahoo.com.br.
(b) Secretaria de Estado da Saúde de São Paulo, São Paulo, SP, Brazil. farid_samaan@yahoo.com.br.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12882-024-03597-9

Comparison between catheter ablation versus permanent pacemaker implantation as an initial treatment for tachycardia-bradycardia syndrome patients: a prospective, randomized trial.

Comparison between catheter ablation versus permanent pacemaker implantation as an initial treatment for tachycardia-bradycardia syndrome patients: a prospective, randomized trial.

Fuente:Bmc Cardiovascular Disorders

Extracto: CA had a similar efficacy and safety profile with that of PM and a higher sinus rhythm maintenance rate. CA could be considered as a preferable initial treatment option over PM implantation in patients with paroxysmal AF and TBS. TRIAL REGISTRATION: KCT0000155.

Claves:Artificial pacemaker, Atrial fibrillation, Catheter ablation, Sick sinus syndrome

Cita:BMC Cardiovasc Disord 2024 May 10; 24 (1) : 246.

Autor/es:Cho, Min Soo (a)
Lee, Ji Hyun (b)

institución:(a) Department of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
(b) Cardiovascular Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12872-024-03920-0

Insight into the research history and trends of total anomalous pulmonary venous connection: a bibliometric analysis.

Insight into the research history and trends of total anomalous pulmonary venous connection: a bibliometric analysis.

Fuente:Journal of Cardiothoracic Surgery

Tipo de trabajo:Caso clínico

Extracto: This study conducted a bibliometric analysis to provide a comprehensive overview of TAPVC research. We hope to offer new ideas for promoting development in the field of TAPVC.

Claves:Bibliometrics, CiteSpace, Hot spot, Research progress, Total anomalous pulmonary venous connection, VOSViewer

Cita:J Cardiothorac Surg 2024 May 11; 19 (1) : 285.

Autor/es:Wen, Chen (a)
Shen, Geng (b)

institución:(a) Department of Cardiothoracic Surgery, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. wenchen1993@sjtu.edu.cn.
(b) Division of Cardiology, Peking University First Hospital, Beijing, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s13019-024-02787-8

Association of RASGRP1 polymorphism with vascular complications in Chinese diabetic patients with glycemic control and antihypertensive treatment.

Association of RASGRP1 polymorphism with vascular complications in Chinese diabetic patients with glycemic control and antihypertensive treatment.

Fuente:Cardiovascular Diabetology

Extracto: We found that patients with G allele of RASGRP1 (rs56254815) showed a better antihypertensive therapy efficacy in T2DM patients. The rs7403531 T allele could reduce the risk of major microvascular events and major eye diseases in T2DM patients receiving either hypoglycemic or antihypertensive therapy. Our findings suggest that RASGRP1 genetic polymorphism might predict the cardiovascular complications in T2DM patients.

Claves:Individual drug treatment, Polymorphism, RASGRP1, Type 2 diabetes, Vascular complications, rs7403531

Cita:Cardiovasc Diabetol 2024 May 10; 23 (1) : 166.

Autor/es:Zhou, Jiecan (a)
Xu, Bo (b)

institución:(a) The First Affiliated Hospital, Hunan Provincial Clinical Medical Research Center for Drug Evaluation of Major Chronic Diseases, Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, China. zhoujiecan@fsyy.usc.edu.cn.
(b) The First Affiliated Hospital, Hengyang Clinical Pharmacology Research Center, Hengyang Medical School, University of South China, 421001, Hengyang, Hunan, China. zhoujiecan@fsyy.usc.edu.cn.

Conflicto:All authors declare no conflict of interest relevant to the subject matter or materials discussed in the article.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12933-024-02267-2

Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.

Fuente:Cardiovascular Diabetology

Extracto: Patients with MASLD are likely to have a higher risk of cardiovascular disease than those with NAFLD. Concurrent assessment of MASLD during CCTA improves the identification of patients at a higher risk of cardiovascular disease among those with clinically indicated CCTA.

Claves:Coronary computed tomography angiography, High-risk plaque, Metabolic dysfunction-associated fatty liver disease, Obstructive stenosis

Cita:Cardiovasc Diabetol 2024 May 10; 23 (1) : 167.

Autor/es:Nishihara, Takahiro (a)
Miyoshi, Toru (b)

institución:(a) Department of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, 700-8558, Okayama, Okayama, Japan.
(b) Department of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, 700-8558, Okayama, Okayama, Japan. miyoshit@cc.okayama-u.ac.jp.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12933-024-02268-1

Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies.

Fuente:Cardiovascular Diabetology

Extracto: Elevated concentrations of plasma CRP and glucose are predictors of IHD and CVD death in the general population. We found no genetic association between CRP and glucose, or vice versa, suggesting that lowering glucose pharmacologically does not have a direct effect on low-grade inflammation.

Claves:Cardiovascular death, Cardiovascular disease, Diabetes, Hyperglycaemia, Low-grade inflammation, Mendelian randomization

Cita:Cardiovasc Diabetol 2024 May 10; 23 (1) : 165.

Autor/es:Rolver, Monica G (a)
Emanuelsson, Frida (b)

institución:(a) Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev Gentofte, Borgmester Ib Juuls Vej 1, Herlev, 2730, Denmark.
(b) Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen, 2200, Denmark.

Conflicto:Monica Gylling Rolver is part-time employed by Novo Nordisk Denmark as a student assistant. Other authors report no conflict of interest related to the present study.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12933-024-02207-0

Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes

Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes

Fuente:Bmc Endocrine Disorders

Tipo de trabajo:Estudio de cohortes

Extracto: The findings of this prospective cohort study conducted in the US indicate a positive association of elevated NLR levels with heightened risks of overall and cardiovascular mortality among adults with diabetes and prediabetes. However, potential confounding factors for NLR and the challenge of monitoring NLR's fluctuations over time should be further focused.

Claves:All-cause mortality, Cardiovascular mortality, Cohort study, Diabetes, Neutrophil-lymphocyte ratio, Prediabetes

Cita:BMC Endocr Disord 2024 May 10; 24 (1) : 64.

Autor/es:Chen, Guangshu (a)
Che, Li (b)

institución:(a) Department of Endocrinology and Metabolism, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, 510220, Guangdong, China.
(b) State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12902-024-01592-7

Enhanced external counterpulsation treatment improves multi-organ hemodynamics for postoperative liver transplantation patient. A case report.

Enhanced external counterpulsation treatment improves multi-organ hemodynamics for postoperative liver transplantation patient. A case report.

Fuente:Journal of Cardiothoracic Surgery

Extracto: We report a case of multi-organ ischemic symptoms in a post LT patient. EECP treatment can significantly improve the quality of life via the systematic promotion of hemodynamics.

Claves:External counterpulsation, Ischemic symptoms, Liver transplantation, Rehabilitation

Cita:J Cardiothorac Surg 2024 May 10; 19 (1) : 284.

Autor/es:Zeng, Xinchen (a)
Jin, Xin (b)

institución:(a) Department of Liver Surgery, The Third People's Hospital of Shenzhen, Shenzhen, 518112, China.
(b) Department of Liver Surgery, The Third People's Hospital of Shenzhen, Shenzhen, 518112, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s13019-024-02783-y